Current efficacy of postexposure prophylaxis against measles with immunoglobulin

A Endo1, H Izumi, M Miyashita

  • 1Division of Pediatrics, Itabashi Ward Medical Association Hospital, Takashimadaira 3-12-6, Itabashi-ku, Tokyo 175-0082, Japan.

Insights

Postexposure prophylaxis for measles using immunoglobulin was assessed. Immunoglobulin with low measles antibody titers (≤16 IU/mL) resulted in 57% of children developing measles, indicating a need for higher titer preparations.

Area of Science:

  • Pediatrics
  • Immunology
  • Infectious Diseases

Background:

  • Measles is a highly contagious viral illness.
  • Postexposure prophylaxis is crucial for preventing measles transmission.
  • Intramuscular immunoglobulin is a common method for prophylaxis.

Purpose of the Study:

  • To evaluate the efficacy of intramuscular immunoglobulin for measles postexposure prophylaxis.
  • To determine the relationship between immunoglobulin measles antibody titer and clinical outcomes.

Main Methods:

  • Children received intramuscular immunoglobulin (0.33 mL/kg) within 5 days of measles exposure.
  • Immunoglobulin preparations with varying measles antibody titers were used.
  • Clinical assessment for measles development was performed.

Main Results:

  • 57% of children receiving immunoglobulin with a measles antibody titer of ≤16 IU/mL developed clinically evident measles.
  • Lower immunoglobulin titers were associated with a higher incidence of measles.

Conclusions:

  • Current immunoglobulin preparations with low measles antibody titers are insufficient for effective postexposure prophylaxis.
  • Higher measles antibody titers in immunoglobulin are required for adequate protection.